• 검색 결과가 없습니다.

Association between Praziquantel and Cholangiocarcinoma in Patients Infected with Opisthorchis viverrini: A Systematic 5HYLHZDQG0HWD$QDO\VLV

N/A
N/A
Protected

Academic year: 2022

Share "Association between Praziquantel and Cholangiocarcinoma in Patients Infected with Opisthorchis viverrini: A Systematic 5HYLHZDQG0HWD$QDO\VLV"

Copied!
6
0
0

로드 중.... (전체 텍스트 보기)

전체 글

(1)

$VLDQ3DFLÀF-RXUQDORI&DQFHU3UHYHQWLRQ9RO

7011

Praziquantel and Cholangiocarcinoma in Patients Infected with Opisthorchis viverrini: A Meta-Analysis

Asian Pac J Cancer Prev, 14 (11), 7011-7016

Introduction

Parasitic diseases associated with cancer remain common and widespread in tropical countries. In Thailand, OLYHUÁXNHLQIHFWLRQZLWKOpisthorchis viverrini remains an important public health problem due to the traditional KXPDQKDELWRIHDWLQJUDZÀVK7KHHDWLQJRIUDZÀVKDQG

FXOWXUDOSRSXODUGLVKHVPDGHZLWKSDUWLDOO\FRRNHGRUUDZ

ÀVKZKLFKPD\FRQWDLQWKHLQIHFWLYHVWDJH PHWDFHUFDULDH  RI O viverrini, has been practised in the northeastern UHJLRQZKHUHDVDFRQVHTXHQFHWKHKLJKHVWSUHYDOHQFH

RI O viverrini LQIHFWLRQ DQG LQFLGHQFH RI VXEVHTXHQW

FKRODQJLRFDUFLQRPD KDYH EHHQ REVHUYHG 6ULSD HW DO

.DHZSLWRRQHWDO*UXQG\HWDO 7KH

SUREOHPLVHQGHPLFLQWKH0HNRQJUHJLRQ,Q7KDLODQG

DQGWKH/DR3HRSOH·V'HPRFUDWLF5HSXEOLF /DRV3'5 

PDQ\SHRSOHDUHLQIHFWHGZLWKWKHOLYHUÁXNHO viverrini, QDPHO\HLJKWPLOOLRQ7KDLDQGWZRPLOOLRQLQ/DRV3'5

$SSUR[LPDWHO\RI7KDLFDVHVRFFXULQWKHQRUWKHUQ

DQGQRUWKHDVWHUQUHJLRQVRI7KDLODQG 6LWKLWKDZRUQDQG

1Cancer Unit, Srinagarind Hospital, 2Department of Biostatistics and Demography, Faculty of Public Health, 3Department of Surgery, Faculty of Medicine, Khon Kaen University, Thailand *For correspondence: joevajara@gmail.com

Abstract

Background: The liver fluke, Opisthorchis viverrini, and the associated incidence of subsequent cholangiocarcinoma (CCA) are still a public health problem in Thailand, and praziquantel (PZQ) remains the antihelminthic drug of choice for treatment. Evidence in hamsters shows that repeated infection and PZQ treatments could increase the risk of CCA. However, the existing evidence in humans is inconclusive regarding increased risk of CCA with frequency of PZQ intake. Objectives: To investigate the relationship between number of repeated PZQ treatments and CCA in patients with O viverrini infection. Materials and Methods: The reviewed studies were searched in EMBASE, MEDLINE, ProQuest, PubMed and SCOPUS from inception to October,

XVLQJSUHVSHFLÀHGNH\ZRUGV7KHULVNRIELDV 52% RILQFOXGHGVWXGLHVZDVLQGHSHQGHQWO\DVVHVVHGE\WZR

UHYLHZHUVXVLQJDTXDOLW\VFDOHIURPWKH1HZFDVWOH2WWDZD6FDOH 126 5LVNHIIHFWRI3=4ZDVHVWLPDWHGDVD

SRROHGRGGVUDWLR 25 ZLWKLWVFRQÀGHQFHLQWHUYDO &, LQWKHUDQGRPHIIHFWVPRGHOXVLQJ'HU6LPRQLDQ

and Laird’s estimator. 5HVXOWV Three studies involving 637 patients were included. Based on the random effects model performed in two included studies of 237 patients, the association between PZQ treatments and CCA was QRWVWDWLVWLFDOVLJQLÀFDQWZLWKDSRROHG25RI &,WR Conclusions: The present systematic review and meta-analysis provides inconclusive evidence of risk effect of PZQ on increasing the risk of CCA and VLJQLÀFDQWPHWKRGRORJLFDOOLPLWDWLRQV)XUWKHUUHVHDUFKLVXUJHQWO\QHHGHGWRDGGUHVVWKHVKRUWFRPLQJVIRXQG

LQWKLVUHYLHZHVSHFLDOO\WKHUHTXLUHPHQWIRUKLVWRORJLFDOFRQÀUPDWLRQ

Keywords: &KRODQJLRFDUFLQRPDOpisthorchis viverriniUHSHDWHGSUD]LTXDQWHOWUHDWPHQWVV\VWHPDWLFUHYLHZ

5(6($5&+$57,&/(

Association between Praziquantel and Cholangiocarcinoma in Patients Infected with Opisthorchis viverrini: A Systematic 5HYLHZDQG0HWD$QDO\VLV

Supot Kamsa-ard

1

, Malinee Laopaiboon

2

, Vor Luvira

3

, Vajarabhongsa Bhudhisawasdi

3

*

+DVZHOO(ONLQV6ULSDHWDO 

 )RU 7KDL SHRSOH WKH DJHVWDQGDUGL]HG UDWH $65  RIOLYHUDQGELOHGXFWFDQFHUVLVEHWZHHQDQG

SHU  SHRSOH LQ PDOHV DQG EHWZHHQ  DQG

 SHU  LQ IHPDOHV &&$ KDV EHHQ GHWHFWHG

DV WKH PRVW FRPPRQ KLVWRORJLFDO W\SH DFFRXQWLQJ IRU

EHWZHHQDQGRIDOOSULPDU\OLYHUFDQFHUV

9DWDQDVDSW HW DO  'HHUDVDPHH HW DO 

6ULSOXQJ HW DO  .KXKDSUHPD HW DO  

  7KH DYHUDJH SUHYDOHQFH RI OLYHU ÁXNH LQIHFWLRQ

caused by O viverriniKDVEHHQUHSRUWHGDVRIWKH

7KDL SRSXODWLRQ -RQJVXNVXQWLJXO   EXW LW ZDV

distributed predominantly in the north and northeast -RQJVXNVXQWLJXO6LWKLWKDZRUQDQG+DVZHOO(ONLQV

 

 /LWWOHHYLGHQFHRIWKHULVNIDFWRUVIRU&&$LVDYDLODEOH

DQGPRVWVWXGLHVKDYHIRFXVHGRQWKHUROHRIO viverrini LQIHFWLRQLQWKHVXEVHTXHQWGHYHORSPHQWRI&&$WKDWLV

WKHDUHDVZLWKDKLJKLQFLGHQFHRI&&$VKRZKLJK29

LQWHQVLWLHV7KHRGGVUDWLRVRIO viverriniLQIHFWLRQKDYH

(2)

$VLDQ3DFLÀF-RXUQDORI&DQFHU3UHYHQWLRQ9RO

7012

UDQJHGIURPWR 3DUNLQHWDO+RQMRHWDO

3RRPSKDNZDHQHWDO ,QDSUHYLRXVVWXG\

UHSRUWLQJSUHYDOHQFHRGGVUDWLRV 325 WKHOLJKWLQIHFWLRQ

JURXSZDVDSSUR[LPDWHO\WLPHVPRUHOLNHO\WRKDYH

&&$WKDQWKHQRQLQIHFWLRQJURXS &,WR  ZKLOH WKH PRGHUDWH LQIHFWLRQ JURXS ZDV DSSUR[LPDWHO\

WLPHVPRUHOLNHO\WRKDYH&&$WKDQWKHQRQLQIHFWLRQ

JURXS &,  WR   DQG WKH KHDY\ LQIHFWLRQ

JURXSZDVDSSUR[LPDWHO\WLPHVPRUHOLNHO\WRKDYH

&&$WKDQWKHQRQLQIHFWLRQJURXS &,WR  +DVZHOO(ONLQV HW DO   ,Q DGGLWLRQ WR KXPDQ

HSLGHPLRORJLFDO VWXGLHV H[SHULPHQWV LQ KDPVWHUV KDYH

also shown that O viverriniLQIHFWLRQLVDVVRFLDWHGZLWK

&&$ %KDPDUDSUDYDWLDQG9LUUDQXYDWWL7KDPDYLW

HWDO6ULSDHWDO6LWKLWKDZRUQ 

 3UD]LTXDQWHO 3=4  LV NQRZQ DV WKH DQWLKHOPLQWKLF

GUXJRIFKRLFHWRWUHDWO viverriniLQIHFWLRQDQGLWSURYLGHV

HIIHFWLYH FKHPRWKHUDS\ :+2   +RZHYHU D

SUHYLRXVVWXG\KDVIRXQGWKDWUDSLGUHLQIHFWLRQFDQRFFXU

DIWHUVXFFHVVIXO3=4WUHDWPHQWV 8SDWKDPHWDO 

3HRSOH HQMR\ HDWLQJ UDZ XQGHUFRRNHG RU LQDGHTXDWHO\

IHUPHQWHGIUHVKZDWHUÀVKDQGEHFDXVHWKH\DUHDZDUHWKDW

3=4LVDQHIIHFWLYHWUHDWPHQWWKH\UHWXUQWRHDWLQJFXOWXUDO

GLVKHV ZKLFK DUH OLNHO\ WR OHDG WR D IXUWKHU O viverrini LQIHFWLRQ 0DQ\ NQRZ WKDW LI WKH\ DUH UHLQIHFWHG WKH\

FDQDJDLQREWDLQWUHDWPHQWZLWK3=4DQGVRWKHF\FOHLV

SHUSHWXDWHG3UHYLRXVVWXGLHVLQKDPVWHUVLQIHFWHGZLWK

O viverrini UHSRUWHG WKDW UHSHDWHG LQIHFWLRQ DQG 3=4

WUHDWPHQWVFDQLQFUHDVHWKHULVNRI&&$ 3LQODRUHWDO

&KDURHQVXNHWDO +RZHYHUWKHIHZ

available studies in humans have shown unclear evidence RIDQLQFUHDVHGULVNRI&&$ZLWKLQFUHDVHGIUHTXHQF\RI

3=4LQWDNH &KHUQUXQJURM $V\VWHPDWLFUHYLHZ

RI WKH FXUUHQWO\ DYDLODEOH HYLGHQFH ZDV SHUIRUPHG WR

LQYHVWLJDWHWKHUHODWLRQVKLSEHWZHHQQXPEHURIUHSHDWHG

3=4 WUHDWPHQWV DQG &&$ LQ SDWLHQWV ZLWK O viverrini LQIHFWLRQV

Materials and Methods

Types of studies

 6WXGLHV ZHUH VHOHFWHG LI WKH\ XVHG DQ\ DQDO\WLFDO

GHVLJQ VXFK DV FDVHFRQWURO PDWFKHG FDVHFRQWURO

QHVWHGFDVHFRQWUROFRKRUWDQGFURVVVHFWLRQDOGHVLJQVWR

LQYHVWLJDWHWKHDVVRFLDWLRQEHWZHHQ3=4WUHDWPHQWVDQG

CCA.

Selection of studied

 6FUHHQV VKRZLQJ WKH WLWOH DEVWUDFW DQG ÀQDOO\ WKH

IXOO WH[W RI SXEOLFDWLRQV ZHUH LQGHSHQGHQWO\ HYDOXDWHG

E\WZRUHVHDUFKHUV6XSRW.DPVDDUG 6. DQG0DOLQHH

/DRSDLERRQ 0/ 'LVDJUHHPHQWZDVUHVROYHGWKURXJK

GLVFXVVLRQ ZLWK D WKLUG UHVHDUFKHU 9DMDUDEKRQJVD

%KXGKLVDZDVGL 9%  Exposure

 7KHH[SRVXUHRILQWHUHVWZDVUHSHDWHGWUHDWPHQWZLWK

3=47KHIUHTXHQF\RI3=4WUHDWPHQWZDVFDWHJRUL]HG

LQWRIRXUGLIIHUHQWJURXSVQHYHUXVHGXVHGRQFHXVHG

WZLFHDQGXVHGPRUHWKDQWZLFH &KHUQUXQJURM 

Outcome

 7KHRXWFRPHZDV&&$&KRODQJLRFDUFLQRPD &&$  is a primary liver cancer, which arises in the epithelial FHOOVOLQLQJWKHLQWUDKHSDWLFDQGH[WUDKHSDWLFELOHGXFWV

EXWZKLFKGRHVQRWLQFOXGHPDOLJQDQFLHVRIWKHJDOOEODGGHU

RUDPSXOODRIYDWHU %KXGKLVDZDVGLHWDO 

Literature research

 ,QDGGLWLRQWRKDQGVHDUFKLQJWKHIROORZLQJGDWDEDVHV

ZHUH VHDUFKHG ZLWKRXW ODQJXDJH UHVWULFWLRQ (0%$6(

0('/,1(3UR4XHVW3XE0HGDQG6&2386

 6HDUFK WHUPV ZHUH XVHG LQ FRPELQDWLRQ DQG

FRYHUHG WKH QDPHV DQG V\QRQ\PV RI ´SUD]LTXDQWHOµ

´FKRODQJLRFDUFLQRPDµ ´FDQFHUµ ´ULVN IDFWRUµ DQG

´Opisthorchis viverriniµ7KHPRUHGHWDLOHGWHUPVXVHG

ZHUHDVIROORZVIRU´SUD]LTXDQWHOµWKHVHZHUH2SWLFLGH

3UDTXDQWHO 3UDVLNRQ 3UD]LWH DQG :RUPLFLGH IRU

´FKRODQJLRFDUFLQRPDµLQWUDKHSDWLFELOHGXFWVLQWUDKHSDWLF

bile duct carcinoma, intrahepatic bile duct cancers, bile duct adenocarcinoma, bile duct cystadenocarcinoma, bile GXFWFDQFHU.ODWVNLQ·VWXPRUSHULKLODUELOHGXFWFDQFHUV

KLODU ELOH GXFW FDQFHUV DQG GLVWDO ELOH GXFW FDQFHUV IRU

´FDQFHUµ WXPRU V  PDOLJQDQF\ DQG FDUFLQRPD IRU

´ULVN IDFWRUµ ULVN DVVRFLDWLRQ UHODWLRQVKLS UHODWLRQ

FRUUHODWLRQFRQQHFWLRQDQG OLQN DQG IRU ´Opisthorchis viverriniµOLYHUÁXNHDQGO viverrini)LJXUHLVDÁRZ

GLDJUDPVKRZLQJWKHDUWLFOHVHOHFWLRQSURFHVV

Study inclusion/exclusion criteria

 7KH LQFOXVLRQ FULWHULD IRU WKH VHOHFWLRQ RI SULPDU\

VWXGLHV ZHUH DV IROORZV i  WKH DUWLFOH LQYHVWLJDWHG WKH

DVVRFLDWLRQ EHWZHHQ IUHTXHQF\ RI 3=4 WUHDWPHQWV DQG

ULVNRI&&$DQGii WKHGLDJQRVLVRI&&$ZDVEDVHGRQ

KLVWRORJLFDO H[DPLQDWLRQ DQG WKH DSSURSULDWH LPDJLQJ

FKDUDFWHULVWLFV7KHH[FOXVLRQFULWHULDZHUHi GXSOLFDWH

DUWLFOHV ZKHUH GXSOLFDWLRQ RFFXUUHG RQO\ RQH RI WKH

)LJXUH)ORZ'LDJUDP6KRZLQJWKH6HOHFWLRQ3URFHVV

IRU$UWLFOHVWREH,QFOXGHGLQWKH6\VWHPDWLF5HYLHZ

(3)

$VLDQ3DFLÀF-RXUQDORI&DQFHU3UHYHQWLRQ9RO

7013

Praziquantel and Cholangiocarcinoma in Patients Infected with Opisthorchis viverrini: A Meta-Analysis articles was included; and ii QRQKXPDQUHVHDUFK

Quality assessment of primary studies

$VVHVVPHQW RI 5LVN RI %LDV 52%  WKH DVVHVVPHQW

RI52%LQWKHLQFOXGHGVWXGLHVDOORIZKLFKXVHGDQRQ

UDQGRPL]HGUHVHDUFKGHVLJQZDVEDVHGRQWKH&RFKUDQH

ULVN RI ELDV WRRO GHYHORSHG E\ WKH 1RQ5DQGRPL]HG

6WXGLHV0HWKRGV*URXS 1560* 7KLVWRROH[DPLQHV

VHOHFWLRQELDVDWWULEXWLRQELDVGHWHFWLRQELDVDQGUHSRUWLQJ

ELDV ZLWK WKH DGGLWLRQ RI WKH LQÁXHQFH RI FRQIRXQGLQJ

YDULDEOHV 1RQ5DQGRPLVHG 6WXGLHV 0HWKRGV *URXS

 7KH SDUWLFXODU LQVWUXPHQW FKRVHQ IRU HYDOXDWLQJ

WKHVWXGLHVDFFRUGLQJWRWKH52%WRROZDVWKH1HZFDVWOH

2WWDZD 6FDOH 126  IRU DVVHVVLQJ WKH TXDOLW\ RI FDVH

FRQWUROVWXGLHV :HOOVHWDO 

'DWD H[WUDFWLRQ DQG PDQDJHPHQW this is an 8-item VFDOHZKLFKFRYHUVWKHDVVHVVPHQWRIFDVHVHOHFWLRQDQG

control selection, study comparability, and exposure. For WKHSXUSRVHRIWKHSUHVHQWUHYLHZWKHVFDOHZDVDGDSWHG

VRWKDWHDFKSULPDU\VWXG\ZDVUDWHGLQWHUPVRID¶ORZ·

¶KLJK·RU¶XQFOHDU·ULVNRIELDVRQHDFKRIWKHHLJKWLWHPV

The adapted scale is reproduced in Table 1. Independent UDWLQJVZHUHPDGHE\6.DQG0/DQGDQ\GLVDJUHHPHQWV

ZHUHUHVROYHGWKURXJKGLVFXVVLRQZLWKWKHWKLUGUHVHDUFKHU

9% 5HYLHZ0DQDJHU6RIWZDUHZDVXVHGWRGRXEOHHQWHU

DOOWKHGDWD 5HY0DQ 

Data analysis

0HDVXUHV RI DVVRFLDWLRQ WKH PDJQLWXGH RI WKH

DVVRFLDWLRQVEHWZHHQ3=4WUHDWPHQWVDQG&&$LQWHUPV

RI3=4XVH FDWHJRUL]HGLQWRWZRGLIIHUHQWJURXSV¶\HV·

RU¶QR· ZHUHSUHVHQWHGLQWKHIRUPRIRGGVUDWLRV 25V  DQGWKHLUFRQÀGHQFHLQWHUYDOV &, 

$VVHVVPHQW RI KHWHURJHQHLW\ KHWHURJHQHLW\ RI WKH

UHVXOWV DFURVV VWXGLHV ZDV DVVHVVHG XVLQJ IRUHVW SORWV

0 25.0 50.0 75.0 100.0

y diagnosed without treatment Newly diagnosed with treatment Persistence or recurrence Remission None Chemotherapy Radiotherapy Concurrent chemoradiation

Table 1. 5LVNRI%LDV 52% ,WHPV$GDSWHGIURP1HZFDVWOH2WWDZD6FDOH 126 V

6(/(&7,21 ,VWKH&DVH'HÀQLWLRQ$GHTXDWH" D \HVORZULVNRIELDV HJHOLJLELOLW\FULWHULDRSHUDWLRQDOGHÀQLWLRQ

  E \HVKLJKULVNRIELDV HJQRWVWDWHGLQSDUW D

  F QRGHVFULSWLRQXQFOHDUULVNRIELDV

 5HSUHVHQWDWLYHQHVVRIWKH&DVHV D \HVORZULVNRIELDV HJFRQVHFXWLYHUHSUHVHQWDWLYHVHULHVRIFDVHV

  E \HVKLJKULVNRIELDV HJQRWVDWLVI\LQJUHTXLUHPHQWVLQSDUW D RUQRWVWDWHG

  F QRGHVFULSWLRQXQFOHDUULVNRIELDV

 6HOHFWLRQRI&RQWUROV D \HVORZULVNRIELDV HJFRPPXQLW\FRQWUROV

  E \HVKLJKULVNRIELDV HJKRVSLWDOFRQWUROV

  F QRGHVFULSWLRQXQFOHDUULVNRIELDV

 'HÀQLWLRQRI&RQWUROV D \HVORZULVNRIELDV HJQRKLVWRU\RI&&$

  E \HVKLJKULVNRIELDV HJQRPHQWLRQRIKLVWRU\RI&&$

  F QRGHVFULSWLRQRIVRXUFHXQFOHDUULVNRIELDV

&203$5$%,/,7< &RPSDUDELOLW\RIFDVHVDQGFRQWUROVRQWKHEDVLVRIWKHGHVLJQRUDQDO\VLV

  D \HVORZULVNRIELDV

HJPDWFKLQJFRQVLGHUDWLRQE\DJHPXOWLSOHDQDO\VLVZLWKDJHDGMXVWHG

  E \HVKLJKULVNRIELDV HJQRWVWDWHGLQSDUW D

  F QRGHVFULSWLRQRIVRXUFHXQFOHDUULVNRIELDV

(;32685( $VFHUWDLQPHQWRIH[SRVXUH D \HVORZULVNRIELDV

VHFXUHUHFRUGHJVXUJLFDOUHFRUGVVWUXFWXUHGLQWHUYLHZZKHUHEOLQGWRFDVHFRQWUROVWDWXV

  E \HVKLJKULVNRIELDV

HJLQWHUYLHZHUQRWEOLQGHGWRFDVHFRQWUROVWDWXVZULWWHQVHOIUHSRUWRUPHGLFDOUHFRUGRQO\

  F QRGHVFULSWLRQRIVRXUFHXQFOHDUULVNRIELDV

 6DPHPHWKRGRIDVFHUWDLQPHQWIRUFDVHVDQGFRQWUROV

  D \HVORZULVNRIELDV HJXVHRIDVWUXFWXUHGTXHVWLRQQDLUH

  E \HVKLJKULVNRIELDV HJQRWVWDWHGLQSDUW D

  F QRGHVFULSWLRQRIVRXUFHXQFOHDUULVNRIELDV

 1RQ5HVSRQVHUDWH D \HVORZULVNRIELDV HJVDPHUDWHIRUERWKJURXSV 

  E \HVKLJKULVNRIELDV HJQRQUHVSRQGHQWVGHVFULEHGUDWHGLIIHUHQWDQGQRGHVLJQDWLRQ

  F QRGHVFULSWLRQRIVRXUFHXQFOHDUULVNRIELDV

WKH&RFKUDQ·V4WHVWDQG,2$QXQDFFHSWDEOHGHJUHHRI

inconsistency across the study outcomes was considered WRKDYHRFFXUUHGZKHQ WKHSYDOXHRI WKH&RFKUDQ·V 4

test statistic was <0.10 and I2ZDV! +LJJLQVHWDO

 

3RROLQJDVVRFLDWLRQDUDQGRPHIIHFWVPRGHOZDVXVHG

WRSRROWKHDVVRFLDWLRQHIIHFWVDFURVVWKHVWXGLHVZKHQWKHUH

ZDVHYLGHQFHRIDQXQDFFHSWDEOHGHJUHHRIKHWHURJHQHLW\

which could not be explained.

Ethnical consideration

 7KLVVWXG\ZDVPHWWKHFULWHULDIRUH[HPSWUHYLHZRI

WKH.KRQ.DHQ8QLYHUVLW\(WKLFV&RPPLWWHHIRU+XPDQ

Research.

5HVXOWV

Characteristics of included studies

 $WRWDORIVWXGLHVZHUHLQGHQWLÀHGXVLQJWKHVHDUFK

VWUDWHJLHV GHVFULEHG DERYH$IWHU UHDGLQJ WKH WLWOHV

DEVWUDFWV DQG IXOOWH[W DUWLFOHV WKUHH UHOHYDQW VWXGLHV

ZHUHVHOHFWHGIRUGHWDLOHGHYDOXDWLRQ$VXPPDU\RIWKHVH

VWXGLHVLQFOXGLQJGHWDLOVRITXDQWLÀFDWLRQRI3=4XVHLV

provided in Table 2.

Risk of bias (ROB)

 7KHUHYLHZDXWKRUVDVVHVVHGWKHTXDOLW\RIWKHWKUHH

VWXGLHVXVLQJWKH52%VFDOH2QHVWXG\ZDVMXGJHGDV

KDYLQJ´XQFOHDUULVNRIELDVµUHJDUGLQJLWVGHÀQLWLRQRI

FRQWUROV1RGHWDLOHGGHÀQLWLRQZDVSURYLGHGDQGFRQWUROV

ZHUHVLPSO\GHVFULEHGDVUDQGRPO\VHOHFWHGVXEMHFWVZKR

had not developed CCA. Furthermore, two studies were DVVHVVHG DV KDYLQJ ´XQFOHDU ULVN RI ELDVµ FRQFHUQLQJ D

ODFNRILQIRUPDWLRQDERXWQRQUHVSRQVHUDWHV )LJXUH

)LJXUH 

(4)

$VLDQ3DFLÀF-RXUQDORI&DQFHU3UHYHQWLRQ9RO

7014

)LJXUH5LVNRI%LDV*UDSK5HYLHZ$XWKRUV·-XGJPHQWVDERXW(DFK5LVNRI%LDV,WHP3UHVHQWHGDV3HUFHQWDJHV

Across All Included Studies

)LJXUH 5LVN RI %LDV 6XPPDU\ 5HYLHZ$XWKRUV·

-XGJPHQWVDERXW(DFK5LVNRI%LDV,WHPIRU(DFKRI

the Included Studies

)LJXUH0HWD$QDO\VLV)RUHVW3ORWVRIWKH5HODWLRQVKLS

between PZQ Treatments and CCA

0DLQÀQGLQJ

 2QH VWXG\ FDWHJRUL]HG 3=4 XVH LQWR IRXU GLIIHUHQW

JURXSV QHYHUXVHGXVHGRQFHXVHGWZLFHDQGXVHGPRUH

WKDQWZLFH  &KHUQUXQJURM DQGIRUWKLVUHDVRQZDV

H[FOXGHGIURPWKHPHWDDQDO\VLV7KHSULPDU\DLPRIWKH

study had been to measure the independent association EHWZHHQXVHRIDOFRKROLFEHYHUDJHVDQG&&$ZKLOHXVHRI

3=4ZDVLQYHVWLJDWHGDVDSRWHQWLDOULVNIDFWRU,QDGGLWLRQ

DOWKRXJK WKH VWXG\ GLG SURYLGH D FOHDU FDVH GHÀQLWLRQ

LQ WHUPV RI WKH 52% VFDOH WKH PHWKRG RI GLDJQRVLV

IRULQFOXVLRQRIPDQ\RIWKHFDVHVFRXOGEHFRQVLGHUHG

XQVDWLVIDFWRU\,QWKHVHOHFWLRQRIFDVHVXVLQJLQIRUPDWLRQ

IURP PHGLFDO UHFRUGV WKH GLDJQRVLV ZDV KLVWRORJLFDOO\

FRQÀUPHGLQRQO\ RXWRI VXEMHFWV)RUWKH

UHPDLQLQJWKHGLDJQRVLVZDVPDGHRQWKHEDVLVRID

FRPELQDWLRQRIXOWUDVRXQG&7DQGFOLQLFDOH[DPLQDWLRQV

 7KH RWKHU WZR VWXGLHV FDWHJRUL]HG 3=4 XVH LQWR

WZR JURXSV ¶QHYHU XVHG· DQG ¶XVHG·  DQG ZHUH DEOH WR

EH LQFOXGHG LQ WKH PHWDDQDO\VLV +RQMR HW DO 

3RRPSKDNZDHQHWDO +RZHYHUWKHRXWFRPHRIWKH

PHWDDQDO\VLVVKRZHGWKDWWKHDVVRFLDWLRQEHWZHHQ3=4

WUHDWPHQWVDQG&&$ZDVLQFRQFOXVLYH:KHQWKHUHVXOWV

RI WKH WZR VWXGLHV ZHUH SRROHG XVLQJ D UDQGRP HIIHFWV

PRGHOWKHRYHUDOO25ZDVZLWKD&,RIWR

 )LJXUH 

Discussion

7KHDLPRIWKLVV\VWHPDWLFUHYLHZZDVWRLQYHVWLJDWH

WKH UHODWLRQVKLS EHWZHHQ 3=4 WUHDWPHQWV DQG &&$ LQ

patients with O viverriniLQIHFWLRQV7KUHHHSLGHPLRORJLFDO

VWXGLHVZHUHIRXQGZKLFKPHWWKHHOLJLELOLW\UHTXLUHPHQWV

IRULQFOXVLRQLQWKHUHYLHZ &KHUQUXQJURM+RQMR

HW DO  3RRPSKDNZDHQ HW DO  $OO ZHUH

FDVHFRQWUROVWXGLHV7ZRRIWKHVWXGLHV &KHUQUXQJURM

+RQMRHWDO IRXQGDVWDWLVWLFDOO\VLJQLÀFDQW

DVVRFLDWLRQEHWZHHQ3=4WUHDWPHQWVDQG&&$ZKLOVWWKH

WKLUG 3RRPSKDNZDHQHWDO GLGQRW8QIRUWXQDWHO\

RQO\WZR +RQMRHWDO3RRPSKDNZDHQHWDO  were able to included in the meta-analysis, and the overall UHVXOW ZDV D QRQVLJQLÀFDQW UHODWLRQVKLS EHWZHHQ 3=4

treatments and CCA.

$ KLVWRORJLFDOO\ FRQILUPHG GLDJQRVLV VKRXOG EH

UHTXLUHG IRU PRVW FDQFHUV ,VDEHO   EXW DOO WKUHH

VWXGLHV IDLOHG WR GR WKLV ,Q WKH VWXG\ E\ &KHUQUXQJURM

  KLVWRORJLFDO FRQÀUPDWLRQ RI &&$ ZDV REWDLQHG

IRURIWKHFDVHVLQ+RQMRHWDO  RQO\

RIWKHFDVHGLDJQRVHVZHUHKLVWRORJLFDOO\FRQÀUPHGDQG

LQ 3RRPSKDNZDHQ HW DO   WKH SHUFHQWDJH LV RQO\

:LWKRXWKLVWRORJLFDOHYLGHQFHVRPHFDVHVPD\EH

LQFRUUHFWO\GLDJQRVHGZLWKWKHUHVXOWWKDWUHDOH[SRVXUH

GLIIHUHQFHVEHWZHHQFDVHVDQGFRQWUROVDUHGLOXWHGDQG

WKHFKDQFHVRIGHPRQVWUDWLQJDQHIIHFWDUHUHGXFHG7KLV

PD\ DW OHDVW SDUWO\ H[SODLQ WKH DEVHQFH RI VWDWLVWLFDOO\

VLJQLÀFDQW RXWFRPH LQ WKH PHWDDQDO\VLV ,Q DGGLWLRQ

WKHUH DSSHDUHG WR EH D KLJK GHJUHH RI KHWHURJHQHLW\ RU

LQFRQVLVWHQF\RIHIIHFWVDFURVVWKHWZRVWXGLHVLQFOXGHG

in the meta-analysis, and this may have contributed to the QRQVLJQLÀFDQWUHVXOW5HJUHWWDEO\LWZDVQRWSRVVLEOHWR

SLQSRLQWWKHVRXUFHVRIWKLVODFNRIFRQVLVWHQF\GXHWKH

OLPLWHGQXPEHURIVWXGLHV

,Q SUHVHQWLQJ WKH UHVXOWV RI WKH DVVHVVPHQW RI 52%

LQWKHWKUHHLQFOXGHGVWXGLHVWZRÀJXUHVZHUHJHQHUDWHG

(5)

$VLDQ3DFLÀF-RXUQDORI&DQFHU3UHYHQWLRQ9RO



Praziquantel and Cholangiocarcinoma in Patients Infected with Opisthorchis viverrini: A Meta-Analysis XVLQJ5HY0DQ 5HY0DQ $52%JUDSKÀJXUHVLOOXVWUDWHVWKHSURSRUWLRQRI

VWXGLHVZLWKHDFKRIWKHDXWKRUV·MXGJPHQWV ¶\HV·¶QR·¶XQFOHDU· IRUHDFKHQWU\

LQWKHWRRO,QRQHRIWKHWZRVWXGLHVLQFOXGHGLQWKHPHWDDQDO\VLVWKHUHZDVDQ

´XQFOHDUULVNRIELDVµDULVLQJIURPWKHODFNRIGHÀQLWLRQRIFRQWUROV,QERWKVWXGLHV

LQFOXGHGLQWKHPHWDDQDO\VLVWKHUHZDVDQ´XQFOHDUULVNRIELDVµGXHWRWKHDEVHQFHV

RILQIRUPDWLRQDERXWUHVSRQVHUDWHV7DNHQWRJHWKHUWKHVHULVNVRIELDVUDLVHIXUWKHU

GRXEWVDERXWWKHYDOLGLW\RIWKHRXWFRPHRIWKHPHWDDQDO\VLV1HYHUWKHOHVVWKH

ULVNRIELDVZDVDVVHVVHGDV´ORZµRQVL[RIWKHHLJKWVLWHPVRIWKH52%VFDOHIRU

all three studies included in the review.

7KHUHZDVDWRWDO&&$SDWLHQWVZLWKLQIHFWHGO viverrini in the three Thailand VWXGLHV:HGLGQRWLQFOXGHGVWXGLHVIURPRWKHUFRXQWULHVVXFKDV/DR3HRSOH·V

'HPRFUDWLF 5HSXEOLF /DRV 3'5  &DPERGLD RU 9LHWQDP 7KLV ZDV EHFDXVH

DVRXUVHDUFKRIGDWDEDVHVLQGLFDWHGWKHUHZHUHQRVWXGLHVLQWKHVHQHLJKERULQJ

FRXQWULHVZKLFKVSHFLÀFDOO\LQYHVWLJDWHGDUHODWLRQVKLSEHWZHHQQXPEHURI3=4

WUHDWPHQWVDQG&&$DOWKRXJKWKHUHZHUHDIHZVWXGLHVZKLFKUHSRUWHGGHVFULSWLYH

data about O viverriniDQG&&$ &KDLHWDO/HHHWDO'HHWDO 

+RZHYHUDVLVJHQHUDOO\NQRZQLQIHFWLRQZLWKO viverrini is endemic in the Lower 0HNRQJUHJLRQ:HWKHUHIRUHQHHGWREHFDXWLRXVDERXWWKHUHSUHVHQWDWLYHQHVVRI

the published articles.

7KHUHZHUHWZRLPSRUWDQWVWUHQJWKVRIWKLVVWXG\)LUVWO\WKLVLVDQDSSURSULDWH

GHVLJQ7KLVLVWKHV\VWHPDWLFUHYLHZRIWKHFXUUHQWO\DYDLODEOHHYLGHQFHZKLFK

ZDVSHUIRUPHGWRLQYHVWLJDWHZKHWKHU3=4WUHDWPHQWVDUHSRVLWLYHO\UHODWHGWRDQ

LQFUHDVHGULVNRI&&$LQSDWLHQWVZLWKO viverrini6HFRQGO\WKHOLWHUDWXUHUHYLHZ

LQFOXGHGDVHDUFKRIWKH(0%$6(0('/,1(3UR4XHVW3XE0HGDQG6&2386

GDWDEDVHVDQGWKHPHWKRGRILGHQWLI\LQJDQGVHOHFWLQJVWXGLHVIRULQFOXVLRQLQWKH

UHYLHZZDVH[SOLFLW7KLVOLPLWHGDQ\ELDVLQWKHFKRLFHRIVWXGLHVIRUUHYLHZDQG

LQFUHDVHGWKHUHOLDELOLW\DQGDFFXUDF\RIWKHFRQFOXVLRQV

7KLVV\VWHPDWLFUHYLHZZDVOLPLWHGE\WKHVFDUFLW\RIVWXGLHVZKLFKZHUHHOLJLEOH

IRULQFOXVLRQLQWKHUHYLHZDQGRQO\RQHVWXG\H[SORUHGIUHTXHQF\RI3=4XVHE\

FDWHJRULVLQJVXEMHFWVLQWRIRXUJURXS QHYHUXVHGXVHGRQFHXVHGWZLFHDQGXVHG

PRUHWKDQWZLFH ZKLOHWKHRWKHUWZRVWXGLHVVLPSO\FDWHJRUL]HGVXEMHFWVLQWRWZR

JURXSV QHYHUXVHGDQGXVHG 7KHQXPEHURIVWXGLHVLQFOXGHGLQWKHUHYLHZDQG

WKH WRWDO VDPSOH VL]H RI &&$ SDWLHQWV LQIHFWHG ZLWK O viverrini included in the VWXGLHVZHUHQRWODUJHHQRXJKDQGWKLVPD\KDYHZHDNHQHGWKHSRZHUDQGKHQFH

WKHYDOLGLW\RIWKHDQDO\VLV7KHRXWFRPHPD\DOVRKDYHEHHQZHDNHQHGE\WKH

DEVHQFHRIKLVWRORJLFDOO\FRQÀUPHGGLDJQRVHV

,Q FRQFOXVLRQ WKH ÀQGLQJV SURYLGH QR ÀUP HYLGHQFH DV WR ZKHWKHU 3=4

WUHDWPHQWVFRXOGLQFUHDVHWKHULVNRI&&$)XUWKHUUHVHDUFKLVQHHGHGWRIRFXVRQWKH

SULPDU\DLPRIDVVHVVLQJWKHUHODWLRQVKLSEHWZHHQQXPEHURI3=4WUHDWPHQWVDQG

&&$XVLQJGHÀQLWLRQVRIFDVHVDQGFRQWUROVZKLFKDUHDGHTXDWHIRUWKHVDWLVIDFWRU\

PHDVXUHPHQW RI RXWFRPH DQG SURYLGLQJ LQIRUPDWLRQ DERXW UHVSRQVH UDWHV ,Q

SDUWLFXODUDKLVWRORJLFDOO\FRQÀUPHGGLDJQRVLVRI&&$VKRXOGEHDUHTXLUHPHQW

LQIXWXUHVWXGLHV

Acknowledgements

7KHDXWKRUWKDQNV D 3URIHVVRU&KRPFKDUN&KDQWUDVDNXO)DFXOW\RI0HGLFLQH

6LULUDM+RVSLWDO0DKLGRO8QLYHUVLW\DQG&HUHERV 7KDLODQG /WGWKRVHIXQGHGWKLV

UHVHDUFK E 3URIHVVRU5RVV+$QGUHZVDWWKH/LYHU)OXNH &KRODQJLRFDUFLQRPD

5HVHDUFK &HQWUH )DFXOW\ RI 0HGLFLQH ..8 IRU KLV KHOSIXO FRPPHQWV F  0V<XZDGHH3KHWFKDUDDOLEUDULDQZKRKHOSHGLQWKHXVHRIVHDUFKHQJLQHV G 

$VVLVWDQW3URIHVVRU3RUMDL3DWWDQLWWXPIRUKHUJXLGDQFHRQWKHXVHRI5HY0DQIRU

FRQGXFWLQJD0HWDDQDO\VLV H 3HWHU%UDGVKDZIRUDVVLVWDQFHZLWKWKHFRQWHQW

DQG(QJOLVKODQJXDJHSUHVHQWDWLRQRIWKHPDQXVFULSWDQG I $VVLVWDQW3URIHVVRU

6LULSRUQ.DPVDDUGZKRHQFRXUDJHGWRZRUNRQV\VWHPDWLFUHYLHZV7KLVVWXG\LV

SDUWRIGRFWRUDOGLVVHUWDWLRQDWWKH*UDGXDWH6FKRRO.KRQ.DHQ8QLYHUVLW\7KDLODQG

5HIHUHQFHV

%KDPDUDSUDYDWL19LUUDQXYDWWL9  /LYHUGLVHDVHVLQ7KDLODQG$QDQDO\VLVRIOLYHU

biopsies. Am J Gastroenterol, , 267-75.

Table 2. Summary of Study Characteristics According to PZQ Treatments $XWKRUV6WXG\GHVLJQ6HWWLQJ&&$&RQWURO&RPPHQWV n Exposuren Exposure &KHUQUXQJURM3RSXODWLRQEDVHGFDVH²FRQWUROVWXG\.KRQ.DHQ7KDLODQG3=4XVHIRXUGLIIHUHQWJURXSV )UHTXHQF\PDWFKHGE\VH[DQGDJH QHYHUXVHGXVHGRQFHXVHGWZLFHDQGXVHGPRUHWKDQWZLFH +RQMRHWDO3RSXODWLRQEDVHGFDVH²FRQWUROVWXG\1DNKRQ3DKQRPSURYLQFLDOKRVSLWDO7UHDWPHQWZLWK3=4WZRGLIIHUHQWJURXSV 1R<HV ,QGLYLGXDOVPDWFKHGE\VH[DJHDQGSODFHRIUHVLGHQFH7KDLODQG² 3RRPSKDNZDHQHWDO 1HVWHGFDVHFRQWUROVWXG\.KRQ.DHQ7KDLODQG+LVWRU\RI3=4XVHWZRGLIIHUHQWJURXSV 1R<HV ,QGLYLGXDOVPDWFKHGE\VH[DJH “\HDUV DQGVDPHSHULRGRI UHFUXLWPHQWWRWKHFRKRUW “PRQWKV

(6)

$VLDQ3DFLÀF-RXUQDORI&DQFHU3UHYHQWLRQ9RO

7016

0 25.0 50.0 75.0 100.0

Newly diagnosed without treatment Newly diagnosed with treatment Persistence or recurrence Remission None Chemotherapy Radiotherapy Concurrent chemoradiation

%KXGKLVDZDVGL 9 .KXQWLNHR 1 &KXULQ 6 HW DO  

&KRODQJLRFDUFLQRPD([SHULHQFHRI6ULQDJDULQG+RVSLWDO

Srinagarind Med J, 27

&KDURHQVXN/3LQODRU33UDNREZRQJ6HWDO  &XUFXPLQ

LQGXFHVDQXFOHDUIDFWRUHU\WKURLGUHODWHGIDFWRUGULYHQ

UHVSRQVH DJDLQVW R[LGDWLYH DQG QLWUDWLYH VWUHVV DIWHU

SUD]LTXDQWHOWUHDWPHQWLQOLYHUÁXNHLQIHFWHGKDPVWHUVInt J Parasitol, 41, 615-26.

&KHUQUXQJURM*  5LVNIDFWRUIRUFKRODQJLRFDUFLQRPDD

FDVHFRQWUROVWXG\'RFWRUDO'LVVHUWDWLRQWRWKH)DFXOW\RI

WKH*UDGXDWH6FKRRO<DOH8QLYHUVLW\

&KDL -< +RQJYDQWKRQJ %  $ VPDOOVFDOH VXUYH\ RI

LQWHVWLQDO KHOPLQWKLF LQIHFWLRQV DPRQJ WKH UHVLGHQWV QHDU

3DNVH/DRVKorean J Parasitol, 36, 55-8.

'H190XUUHOO.'&RQJ/'HWDO  7KHIRRGERUQH

WUHPDWRGH ]RRQRVHV RI 9LHWQDP Southeast Asian J Trop Med Public Health, 34

'HHUDVDPHH60DUWLQ16RQWLSRQJ6HWDO  &DQFHULQ

7KDLODQG9RO,,,$5&7HFKQLFDO5HSRUW1R

/\RQ,$5&

GRV 6DQWRV 6LOYD ,   &DQFHU HSLGHPLRORJ\ 3ULQFLSOHV

DQGPHWKRGV,$5& ,QWHUQDWLRQDO$JHQF\IRU5HVHDUFKRQ

&DQFHU /\RQ,QWHUQDWLRQDO$JHQF\IRU5HVHDUFKRQ&DQFHU

*UXQG\:DUU &$QGUHZV 5+ 6LWKLWKDZRUQ 3 HW DO  

5DZDWWLWXGHVZHWODQGFXOWXUHVOLIHF\FOHVVRFLRFXOWXUDO

G\QDPLFVUHODWLQJWROpisthorchis viverriniLQWKH0HNRQJ

%DVLQParasitol Int, 61, 65-70.

+DVZHOO(ONLQV 05 0DLULDQJ ( 0DLULDQJ 3 HW DO  

&URVVVHFWLRQDOVWXG\RIOpisthorchis viverriniLQIHFWLRQDQG

FKRODQJLRFDUFLQRPDLQFRPPXQLWLHVZLWKLQDKLJKULVNDUHD

in northeast Thailand. Int J Cancer, 

+LJJLQV-377KRPSVRQ6*'HHNV--HWDO  0HDVXULQJ

inconsistency in meta-analyses. BMJ, 327, 557-60.

+RQMR66ULYDWDQDNXO36ULSOXQJ+HWDO  *HQHWLFDQG

HQYLURQPHQWDOGHWHUPLQDQWVRIULVNIRUFKRODQJLRFDUFLQRPD

via Opisthorchis viverrini LQ D GHQVHO\ LQIHVWHG DUHD LQ

1DNKRQ 3KDQRP QRUWKHDVW 7KDLODQG Int J Cancer, 117,



-RQJVXNVXQWLJXO 3   6HPLQDU LQ 3DUDVLWLF 'LVHDVHV

LQ QRUWKHDVW 7KDLODQG .OXQJQDQD 9LWD\D .KRQ .DHQ

7KDLODQG3DUDVLWLFGLVHDVHLQ1RUWKHDVW7KDLODQG

.DHZSLWRRQ 1 .DHZSLWRRQ 6- 3HQJVDD 3  

2SLVWKRUFKLDVLV LQ 7KDLODQG UHYLHZ DQG FXUUHQW VWDWXV

World J. Gastroenterol, 14

.KXKDSUHPD7$WWDVDUD36ULSOXQJ+HWDO  /LYHUDQG

%LOHGXFWCancer in Thailand, 6

.KXKDSUHPD76ULYDWDQDNXO3$WWDVDUD3HWDO  /LYHU

DQG%LOHGXFWCancer in Thailand, 

.KXKDSUHPD76ULYDWDQDNXO36ULSOXQJ+HWDO  /LYHU

DQG%LOHGXFW&DQFHULQ7KDLODQG

/HH.-%DH<7.LP'+HWDO  6WDWXVRILQWHVWLQDO

SDUDVLWHV LQIHFWLRQ DPRQJ SULPDU\ VFKRRO FKLOGUHQ LQ

.DPSRQJFKDP&DPERGLDKorean J Parasitol, 40

1RQ5DQGRPL]HG 6WXGLHV 0HWKRGV *URXS 1560*   

The Cochrane Collaboration.

3DUNLQ'06ULYDWDQDNXO3.KODW0HWDO  /LYHUFDQFHU

LQ7KDLODQG,$FDVHFRQWUROVWXG\RIFKRODQJLRFDUFLQRPD

Int J Cancer, 

3LQODRU 6 0D 1 +LUDNX< HW DO   5HSHDWHG LQIHFWLRQ

with Opisthorchis viverrini LQGXFHV DFFXPXODWLRQ RI

QLWURJXDQLQHDQGR[RGLK\GUR·GHR[\JXDQLQHLQ

WKHELOHGXFWRIKDPVWHUVYLDLQGXFLEOHQLWULFR[LGHV\QWKDVH

Carcinogenesis, 

3LQODRU 6 3UDNREZRQJ 6 %RRQPDUV 7 HW DO   (IIHFW

RI SUD]LTXDQWHO WUHDWPHQW RQ WKH H[SUHVVLRQ RI PDWUL[

0HWDOORSURWHLQDVHV LQ UHODWLRQ WR WLVVXH UHVRUSWLRQ GXULQJ

ÀEURVLV LQ KDPVWHUV ZLWK DFXWH DQG FKURQLF Opisthorchis

viverriniLQIHFWLRQActa Tropica, 111

3RRPSKDNZDHQ.3URPWKHW6.DPVDDUG6HWDO  5LVN

)DFWRUVIRU&KRODQJLRFDUFLQRPDLQ.KRQ.KDHQ7KDLODQG

$ 1HVWHG &DVH&RQWURO 6WXG\ Asian Pac J Cancer Prev, 10, 251-7.

5HY0DQ  7KH&RFKUDQH&ROODERUDWLRQ5HYLHZ0DQDJHU

5HY0DQ &RSHQKDJHQ7KH1RUGLF&RFKUDQH&HQWUH

The Cochrane Collaboration.

6LWKLWKDZRUQ 3   &XUUHQW 5ROHV RI /LYHU )OXNH RQ

2FFXUUHQFH RI &KRODQJLRFDUFLQRPD Srinagarind Med J, 20

6LWKLWKDZRUQ 3 +DVZHOO(ONLQV 0   (SLGHPLRORJ\ RI

Opisthorchis viverrini. Acta Trop, 

6ULSD%%HWKRQ\-06LWKLWKDZRUQ3HWDO  2SLVWKRUFKLDVLV

DQG2SLVWKRUFKLVDVVRFLDWHGFKRODQJLRFDUFLQRPDLQ7KDLODQG

and Laos. Acta Trop, 120, 158-68.

6ULSD%.DHZNHV66LWKLWKDZRUQ3HWDO  /LYHUÁXNH

LQGXFHVFKRODQJLRFDUFLQRPD PLoS Med, 4, 201.

6ULSD % <RQJYDQLW 3 3DLURMNXO &   (WLRORJ\ DQG

SDWKRJHQHVLV RI FKRODQJLRFDUFLQRPD LQWURGXFWLRQ WR WKH

DVVRFLDWLRQZLWKOLYHUÁXNHLQIHFWLRQSrinagarind Med J, 20

6ULSOXQJ + 6RQWLSRQJ 6 0DUWLQ 1 HW DO   &DQFHU LQ

7KDLODQG9RO,,,%DQJNRN%DQJNRN0HGLFDO

Publisher.

7KDPDYLW:%KDPDUDSUDYDWL16DKDSKRQJ6HWDO  (IIHFWV

RIGLPHWK\OQLWURVDPLQHRQLQGXFWLRQRIFKRODQJLRFDUFLQRPD

in Opisthorchis viverriniLQIHFWHG6\ULDQJROGHQKDPVWHUV

Cancer Res, 

8SDWKDP(69L\DQDQW9%URFNHOPDQ:<HWDO  5DWH

RI UHLQIHFWLRQ E\ Opisthorchis viverrini in an endemic QRUWKHDVW 7KDL FRPPXQLW\ DIWHU FKHPRWKHUDS\ Int J Parasitol, 

9DWDQDVDSW 9 0DUWLQ 1 6ULSOXQJ + HW DO   &DQFHU LQ

7KDLODQG  ,$5& 7HFKQLFDO 5HSRUW 1R  

Lyon, IARC.

:HOOV*$6KHD%2·&RQQHOO'HWDO  7KH1HZFDVWOH

2WWDZD 6FDOH 126  IRU DVVHVVLQJ WKH TXDOLW\ RI

nonrandomised studies in meta-analyses.

:+2  &RQWURORIIRRGERUQHWUHPDWRGHLQIHFWLRQV5HSRUW

RID:+26WXG\*URXSWorld Health Organ Tech Rep Ser,

, 1-157.

참조

관련 문서

• 대부분의 치료법은 환자의 이명 청력 및 소리의 편안함에 대한 보 고를 토대로

12) Maestu I, Gómez-Aldaraví L, Torregrosa MD, Camps C, Llorca C, Bosch C, Gómez J, Giner V, Oltra A, Albert A. Gemcitabine and low dose carboplatin in the treatment of

In our study of 52 coronary artery disease patients undergoing several mea- surements of studied parameters, we observed a significant association between heart

[13,14] Therefore, we investigated the relationship between metformin use and cancer incidence in Korean patients with T2DM using the Korean National Diabetes Program (KNDP)

Background: To investigate the association between diabetic retinopathy (DR) and myocardial dysfunction in patients with type 2 diabetes and dilated cardiomyopathy (dCMP)..

The extracted topics were public health policies, social inequalities in health, inequality as a social problem, healthcare policies, and regional health gaps.. The total

Background: Multimorbidity is a common problem in the elderly and is significantly associated with functional decline, disability, and mortality.. However,

Background: In the current study, we investigated whether the laboratory and clinical manifestations of SS patients were associated with CCL21 and CXCL13 expression levels